The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Safety and efficacy of intravesical nadofaragene firadenovec for patients with high-grade, BCG unresponsive nonmuscle invasive bladder cancer (NMIBC): Results from a phase III trial.

Stephen A.  Boorjian

Consulting or Advisory Role - Ferring; Sanofi

Colin P.N.  Dinney

Consulting or Advisory Role - FKD Therapies; Merck; NCI

Research Funding - FKD Therapies; Merck; NCI; University of Eastern Finland (Inst)